InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
10
T+90 hit rate
0%
T+90 mean return
-37.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Goeltz II Robert C., Chief Financial Officer. Director active across 1 company, notably Arcus Biosciences, Inc.. In total, 17 reports have been recorded. Split: 0 buy · 10 sells. Total volume traded: €758k. History available since 16 December 2021. The latest transaction was disclosed on 11 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations17 total
7,763 shares@ US$25.630.0055% mcap31.6% of flowCommon StockSEC:0001653881-26-000005
7,763 shares@ US$25.630.0056% mcap31.6% of flowCommon StockSEC:0001653881-26-000005:0
5,000 shares@ US$20.0016.1% of flowCommon StockSEC:0001653881-25-000005
5,000 shares@ US$20.000.0029% mcap16.1% of flowCommon StockSEC:0001653881-25-000005:0
37,000 shares0Common StockSEC:0001724521-25-000017:0
3,594 shares@ US$15.005.4% of flowCommon StockSEC:0001724521-25-000002:0
10,099 shares@ US$16.0816.2% of flowCommon StockSEC:0001724521-24-000180:0
22,000 shares0Common StockSEC:0001724521-24-000057:0
21,300 shares0Common StockSEC:0001724521-24-000030:0
2,004 shares@ US$20.003.8% of flowCommon StockSEC:0001724521-24-000009:0
2,749 shares@ US$17.744.7% of flowCommon StockSEC:0001724521-23-000067:0
4,049 shares@ US$20.047.9% of flowCommon StockSEC:0001209191-23-035740:0
34,000 shares0Common StockSEC:0001209191-23-004875:0
2,066 shares@ US$30.666.2% of flowCommon StockSEC:0001209191-22-061762:0
15,500 shares0Common StockSEC:0001209191-22-017984:0
354 shares@ US$39.59160.0004% mcap4.6% of flowCommon StockSEC:0001209191-21-070565
354 shares@ US$39.59160.0004% mcap2.3% of flowCommon StockSEC:0001209191-21-070565:0
17 of 17 declarations
About Goeltz II Robert C.
Robert C. Goeltz II is the Chief Financial Officer at Arcus Biosciences, Inc. He is responsible for financial management and strategy for the company. His financial expertise is essential for supporting Arcus's growth and sustainability.
